A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias
- 27 July 2006
- journal article
- Published by Springer Nature in Leukemia
- Vol. 20 (10) , 1899-1903
- https://doi.org/10.1038/sj.leu.2404331
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutationsLeukemia, 2006
- Nucleophosmin Mutations in De novo Acute Myeloid Leukemia: The Age-Dependent Incidences and the Stability during Disease EvolutionCancer Research, 2006
- Development of a quantitative real‐time polymerase chain reaction method for monitoring CEBPA mutations in normal karyotype acute myeloid leukaemiaBritish Journal of Haematology, 2006
- Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotypeBlood, 2005
- Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemiaBlood, 2005
- Genetics of Myeloid Malignancies: Pathogenetic and Clinical ImplicationsJournal of Clinical Oncology, 2005
- Characterization of CEBPA Mutations in Acute Myeloid Leukemia: Most Patients with CEBPA Mutations Have Biallelic Mutations and Show a Distinct Immunophenotype of the Leukemic CellsClinical Cancer Research, 2005
- Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal KaryotypeNew England Journal of Medicine, 2005
- CEBPA point mutations in hematological malignanciesLeukemia, 2005
- Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemiaBritish Journal of Haematology, 2003